
|Articles|May 7, 2007
New options put squeeze on prostate cancer
New drugs pending for prostate cancer: sipuleucel-T; DCVax-Prostate; satraplatin
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
McKesson Partners with Pharmacies to Grow, Navigate Challenges
2
HHS Claims ACIP Cannot Meet for Flu Season Due to Ongoing Legal Battle
3
US Controlled Substance Market Expected to Grow $21 Billion by 2035
4
FAQ: The Medicare GLP-1 Bridge—What Independent Pharmacists Need to Know
5




































